94 related articles for article (PubMed ID: 24189329)
1. Log reduction of multidrug-resistant Gram-negative bacteria by the neutrophil-derived recombinant bactericidal/permeability-increasing protein.
Weitz A; Spotnitz R; Collins J; Ovadia S; Iovine NM
Int J Antimicrob Agents; 2013 Dec; 42(6):571-4. PubMed ID: 24189329
[TBL] [Abstract][Full Text] [Related]
2. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blood ex vivo.
Levy O; Sisson RB; Kenyon J; Eichenwald E; Macone AB; Goldmann D
Infect Immun; 2000 Sep; 68(9):5120-5. PubMed ID: 10948134
[TBL] [Abstract][Full Text] [Related]
4. The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo.
Elsbach P; Weiss J; Doerfler M; Shu C; Kohn F; Ammons WS; Kung AH; Meszaros KK; Parent JB
Prog Clin Biol Res; 1994; 388():41-51. PubMed ID: 7831373
[TBL] [Abstract][Full Text] [Related]
5. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
[TBL] [Abstract][Full Text] [Related]
6. Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli.
Capodici C; Chen S; Sidorczyk Z; Elsbach P; Weiss J
Infect Immun; 1994 Jan; 62(1):259-65. PubMed ID: 8262637
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
Chockalingam A; Zarlenga DS; Bannerman DD
Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
[TBL] [Abstract][Full Text] [Related]
8. Bactericidal permeability-increasing protein in host defence against gram-negative bacteria and endotoxin.
Elsbach P
Ciba Found Symp; 1994; 186():176-87; discussion 187-9. PubMed ID: 7768151
[TBL] [Abstract][Full Text] [Related]
9. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide.
Elsbach P; Weiss J
Immunobiology; 1993 Apr; 187(3-5):417-29. PubMed ID: 8330906
[TBL] [Abstract][Full Text] [Related]
10. rBPI(21) promotes lipopolysaccharide aggregation and exerts its antimicrobial effects by (hemi)fusion of PG-containing membranes.
Domingues MM; Castanho MA; Santos NC
PLoS One; 2009 Dec; 4(12):e8385. PubMed ID: 20027298
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.
Rauniyar RK; Suzuma K; King AL; Aiello LP; King GL
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):503-9. PubMed ID: 11818397
[TBL] [Abstract][Full Text] [Related]
12. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity.
Marra MN; Wilde CG; Griffith JE; Snable JL; Scott RW
J Immunol; 1990 Jan; 144(2):662-6. PubMed ID: 2295804
[TBL] [Abstract][Full Text] [Related]
13. Inclusion of S-sepharose beads in the culture medium significantly improves recovery of secreted rBPI(21) from transfected CHO-K1 cells.
Horwitz AH; Carroll SF; Williams RE; Liu PS
Protein Expr Purif; 2000 Feb; 18(1):77-85. PubMed ID: 10648172
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of the bactericidal/permeability-increasing protein.
Levy O
Expert Opin Investig Drugs; 2002 Feb; 11(2):159-67. PubMed ID: 11829710
[TBL] [Abstract][Full Text] [Related]
15. Bactericidal/permeability-increasing protein protects vascular endothelial cells from lipopolysaccharide-induced activation and injury.
Arditi M; Zhou J; Huang SH; Luckett PM; Marra MN; Kim KS
Infect Immun; 1994 Sep; 62(9):3930-6. PubMed ID: 8063410
[TBL] [Abstract][Full Text] [Related]
16. Investigation of antibiotic resistance in the genomic era of multidrug-resistant Gram-negative bacilli, especially Enterobacteriaceae, Pseudomonas and Acinetobacter.
Diene SM; Rolain JM
Expert Rev Anti Infect Ther; 2013 Mar; 11(3):277-96. PubMed ID: 23458768
[TBL] [Abstract][Full Text] [Related]
17. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin.
Marra MN; Wilde CG; Collins MS; Snable JL; Thornton MB; Scott RW
J Immunol; 1992 Jan; 148(2):532-7. PubMed ID: 1729370
[TBL] [Abstract][Full Text] [Related]
18. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Ratz CA; Johnston JW; Haseman JR; Gray BH; Dunn DL
J Surg Res; 1996 Jun; 63(1):44-8. PubMed ID: 8661170
[TBL] [Abstract][Full Text] [Related]
19. rBPI(10-193) is secreted by CHO cells and retains the activity of rBPI21.
Horwitz AH; Ammons WS; Bauer RJ; Dedrick R; Nadell R; Williams RE; Liu PS
J Endotoxin Res; 2004; 10(2):97-106. PubMed ID: 15120000
[TBL] [Abstract][Full Text] [Related]
20. The bactericidal/permeability-increasing protein (BPI) in the innate defence of the lower airways.
Holweg A; Schnare M; Gessner A
Biochem Soc Trans; 2011 Aug; 39(4):1045-50. PubMed ID: 21787345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]